Chemoembolization for Hepatocellular Carcinoma

• Status: Terminated
• Trial end date: 2017-08-01

Summary

The aim of the current study is to study the safety and effectiveness of TACE using a high dose of cisplatin for treatment of HCC. It is hypothesized that the formulation is safe and it improves the therapeutic effect of conventional TACE.

• Phase: Phase 2

Details

• Lead Sponsor: Chinese University of Hong Kong
• Treatments: Antineoplastic Agents; Cisplatin